As a researcher and drug development professional, FDA and other agencies are becoming more focused on precision and personalized medicine. We help clients in early-stage studies to determine if genetics impacts responses. In later trials requiring extensive patient stratification Pharmacogenetic test (PGx) can be used.

Use of PGx for clinical trials helps identifying right volunteers and which in-turn contributes to the successful trails with desired output eliminating individual differences because of gene variations.

Prior PGx test of volunteers is recommended before forming a cohort for a said study.